New substituted 4-arylaminoquinazolines as potent inhibitors of breast tumor cell lines: in vitro and docking experiments. [electronic resource]
- European journal of medicinal chemistry Sep 2010
- 4339-42 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1768-3254
10.1016/j.ejmech.2010.04.034 doi
Breast Neoplasms--pathology Cell Line, Tumor ErbB Receptors--antagonists & inhibitors Humans Models, Molecular Protein Conformation Quinazolines--chemical synthesis